GlaxoSmithKline Pharmaceuticals Limited — Others, 11-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

GlaxoSmithKline Pharmaceuticals Limited has announced a board meeting to consider the financial results for the quarter and half-year. The company’s registrar and share transfer agent, Kfin Technologies, confirmed that all securities received for dematerialisation during the quarter were processed and listed on stock exchanges where existing securities trade. Physical certificates were cancelled and ownership records updated within 30 days, ensuring smooth shareholding management and compliance. This update reflects ongoing operational efficiency in handling shareholder securities.